Solute carrier organic anion transporter family member 1B3
Details
- Name
- Solute carrier organic anion transporter family member 1B3
- Synonyms
- Liver-specific organic anion transporter 2
- LST-2
- LST2
- OATP-8
- OATP1B3
- OATP8
- Organic anion transporter 8
- Organic anion-transporting polypeptide 8
- SLC21A8
- Solute carrier family 21 member 8
- Gene Name
- SLCO1B3
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0007032|Solute carrier organic anion transporter family member 1B3 MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKISITQIERRFD ISSSLAGLIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCLLMGTGSILTSLPHFFMGY YRYSKETHINPSENSTSSLSTCLINQTLSFNGTSPEIVEKDCVKESGSHMWIYVFMGNML RGIGETPIVPLGISYIDDFAKEGHSSLYLGSLNAIGMIGPVIGFALGSLFAKMYVDIGYV DLSTIRITPKDSRWVGAWWLGFLVSGLFSIISSIPFFFLPKNPNKPQKERKISLSLHVLK TNDDRNQTANLTNQGKNVTKNVTGFFQSLKSILTNPLYVIFLLLTLLQVSSFIGSFTYVF KYMEQQYGQSASHANFLLGIITIPTVATGMFLGGFIIKKFKLSLVGIAKFSFLTSMISFL FQLLYFPLICESKSVAGLTLTYDGNNSVASHVDVPLSYCNSECNCDESQWEPVCGNNGIT YLSPCLAGCKSSSGIKKHTVFYNCSCVEVTGLQNRNYSAHLGECPRDNTCTRKFFIYVAI QVINSLFSATGGTTFILLTVKIVQPELKALAMGFQSMVIRTLGGILAPIYFGALIDKTCM KWSTNSCGAQGACRIYNSVFFGRVYLGLSIALRFPALVLYIVFIFAMKKKFQGKDTKASD NERKVMDEANLEFLNNGEHFVPSAGTDSKTCNLDMQDNAAAN
- Number of residues
- 702
- Molecular Weight
- 77402.175
- Theoretical pI
- 8.95
- GO Classification
- Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / integral component of plasma membrane / plasma membrane
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP). Involved in the clearance of bile acids and organic anions from the liver.
- Pfam Domain Function
- Transmembrane Regions
- 29-48 68-88 95-119 169-197 217-237 256-280 332-353 374-397 402-425 538-560 570-595 630-647
- Cellular Location
- Basolateral cell membrane
- Gene sequence
>lcl|BSEQ0012544|Solute carrier organic anion transporter family member 1B3 (SLCO1B3) ATGGACCAACATCAACATTTGAATAAAACAGCAGAGTCAGCATCTTCAGAGAAAAAGAAA ACAAGACGCTGCAATGGATTCAAGATGTTCTTGGCAGCCCTGTCATTCAGCTATATTGCT AAAGCACTAGGTGGAATCATTATGAAAATTTCCATCACTCAAATAGAAAGGAGATTTGAC ATATCCTCTTCTCTTGCTGGTTTAATTGATGGAAGCTTTGAAATTGGAAATTTGCTTGTG ATTGTATTTGTAAGTTACTTTGGATCTAAACTACACAGACCGAAGTTAATTGGAATTGGT TGTCTCCTTATGGGAACTGGAAGTATTTTGACATCTTTACCACATTTCTTCATGGGATAT TATAGGTATTCTAAAGAAACCCATATTAATCCATCAGAAAATTCAACATCAAGTTTATCA ACCTGTTTAATTAATCAAACCTTATCATTCAATGGAACATCACCTGAGATAGTAGAAAAA GATTGTGTAAAGGAATCTGGGTCACACATGTGGATCTATGTCTTCATGGGGAATATGCTT CGTGGCATAGGGGAAACCCCCATAGTACCATTGGGGATTTCATACATTGATGATTTTGCA AAAGAAGGACATTCTTCCTTGTATTTAGGTAGTTTGAATGCAATAGGAATGATTGGTCCA GTCATTGGCTTTGCACTGGGATCTCTGTTTGCTAAAATGTACGTGGATATTGGATATGTA GATCTGAGCACTATCAGAATAACTCCTAAGGACTCTCGTTGGGTTGGAGCTTGGTGGCTT GGTTTCCTTGTGTCTGGACTATTTTCCATTATTTCTTCCATACCATTTTTTTTCTTGCCG AAAAATCCAAATAAACCACAAAAAGAAAGAAAAATTTCACTATCATTGCATGTGCTGAAA ACAAATGATGATAGAAATCAAACAGCTAATTTGACCAACCAAGGAAAAAATGTTACCAAA AATGTGACTGGTTTTTTCCAGTCTTTGAAAAGCATCCTTACCAATCCCCTGTATGTTATA TTTCTGCTTTTGACATTGTTACAAGTAAGCAGCTTTATTGGTTCTTTTACTTACGTCTTT AAATATATGGAGCAACAGTACGGTCAGTCTGCATCTCATGCTAACTTTTTGTTGGGAATC ATAACCATTCCTACGGTTGCAACTGGAATGTTTTTAGGAGGATTTATCATTAAAAAATTC AAATTGTCTTTAGTTGGAATTGCCAAATTTTCATTTCTTACTTCGATGATATCCTTCTTG TTTCAACTTCTATATTTCCCTCTAATCTGCGAAAGCAAATCAGTTGCCGGCCTAACCTTG ACCTATGATGGAAATAATTCAGTGGCATCTCATGTAGATGTACCACTTTCTTATTGCAAC TCAGAGTGCAATTGTGATGAAAGTCAGTGGGAACCAGTCTGTGGGAACAATGGAATAACT TACCTGTCACCTTGTCTAGCAGGATGCAAATCCTCAAGTGGTATTAAAAAGCATACAGTG TTTTATAACTGTAGTTGTGTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCACAC TTGGGTGAATGCCCAAGAGATAATACTTGTACAAGGAAATTTTTCATCTATGTTGCAATT CAAGTCATAAACTCTTTGTTCTCTGCAACAGGAGGTACCACATTTATCTTGTTGACTGTG AAGATTGTTCAACCTGAATTGAAAGCACTTGCAATGGGTTTCCAGTCAATGGTTATAAGA ACACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATAAAACATGTATG AAGTGGTCCACCAACAGCTGTGGAGCACAAGGAGCTTGTAGGATATATAATTCCGTATTT TTTGGAAGGGTCTACTTGGGCTTATCTATAGCTTTAAGATTCCCAGCACTTGTTTTATAT ATTGTTTTCATTTTTGCTATGAAGAAAAAATTTCAAGGAAAAGATACCAAGGCATCGGAC AATGAAAGAAAAGTAATGGATGAAGCAAACTTAGAATTCTTAAATAATGGTGAACATTTT GTACCTTCTGCTGGAACAGATAGTAAAACATGTAATTTGGACATGCAAGACAATGCTGCT GCCAACTAA
- Chromosome Location
- 12
- Locus
- 12p12
- External Identifiers
Resource Link UniProtKB ID Q9NPD5 UniProtKB Entry Name SO1B3_HUMAN GenBank Protein ID 9187497 GenBank Gene ID AJ251506 HGNC ID HGNC:10961 - General References
- Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article]
- Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99. [Article]
- Scherer SE, Muzny DM, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Montgomery KT, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Lovering RC, Wheeler DA, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clerc-Blankenburg KP, Davis C, Delgado O, Dinh HH, Draper H, Gonzalez-Garay ML, Havlak P, Jackson LR, Jacob LS, Kelly SH, Li L, Li Z, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Pasternak S, Perez LM, Plopper FJ, Santibanez J, Shen H, Tabor PE, Verduzco D, Waldron L, Wang Q, Williams GA, Zhang J, Zhou J, Allen CC, Amin AG, Anyalebechi V, Bailey M, Barbaria JA, Bimage KE, Bryant NP, Burch PE, Burkett CE, Burrell KL, Calderon E, Cardenas V, Carter K, Casias K, Cavazos I, Cavazos SR, Ceasar H, Chacko J, Chan SN, Chavez D, Christopoulos C, Chu J, Cockrell R, Cox CD, Dang M, Dathorne SR, David R, Davis CM, Davy-Carroll L, Deshazo DR, Donlin JE, D'Souza L, Eaves KA, Egan A, Emery-Cohen AJ, Escotto M, Flagg N, Forbes LD, Gabisi AM, Garza M, Hamilton C, Henderson N, Hernandez O, Hines S, Hogues ME, Huang M, Idlebird DG, Johnson R, Jolivet A, Jones S, Kagan R, King LM, Leal B, Lebow H, Lee S, LeVan JM, Lewis LC, London P, Lorensuhewa LM, Loulseged H, Lovett DA, Lucier A, Lucier RL, Ma J, Madu RC, Mapua P, Martindale AD, Martinez E, Massey E, Mawhiney S, Meador MG, Mendez S, Mercado C, Mercado IC, Merritt CE, Miner ZL, Minja E, Mitchell T, Mohabbat F, Mohabbat K, Montgomery B, Moore N, Morris S, Munidasa M, Ngo RN, Nguyen NB, Nickerson E, Nwaokelemeh OO, Nwokenkwo S, Obregon M, Oguh M, Oragunye N, Oviedo RJ, Parish BJ, Parker DN, Parrish J, Parks KL, Paul HA, Payton BA, Perez A, Perrin W, Pickens A, Primus EL, Pu LL, Puazo M, Quiles MM, Quiroz JB, Rabata D, Reeves K, Ruiz SJ, Shao H, Sisson I, Sonaike T, Sorelle RP, Sutton AE, Svatek AF, Svetz LA, Tamerisa KS, Taylor TR, Teague B, Thomas N, Thorn RD, Trejos ZY, Trevino BK, Ukegbu ON, Urban JB, Vasquez LI, Vera VA, Villasana DM, Wang L, Ward-Moore S, Warren JT, Wei X, White F, Williamson AL, Wleczyk R, Wooden HS, Wooden SH, Yen J, Yoon L, Yoon V, Zorrilla SE, Nelson D, Kucherlapati R, Weinstock G, Gibbs RA: The finished DNA sequence of human chromosome 12. Nature. 2006 Mar 16;440(7082):346-51. [Article]
- van de Steeg E, Stranecky V, Hartmannova H, Noskova L, Hrebicek M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RP, Kenworthy KE, Sticova E, al-Edreesi M, Knisely AS, Kmoch S, Jirsa M, Schinkel AH: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012 Feb;122(2):519-28. doi: 10.1172/JCI59526. Epub 2012 Jan 9. [Article]
- Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article]
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB01045 Rifampicin approved unknown substrateinhibitor Details DB01132 Pioglitazone approved, investigational unknown inhibitor Details DB04348 Taurocholic acid approved, experimental unknown substrate Details DB00286 Conjugated estrogens approved unknown substrate Details DB02659 Cholic Acid approved unknown substrate Details DB00279 Liothyronine approved, vet_approved unknown substrate Details DB01092 Ouabain approved unknown substrate Details DB00563 Methotrexate approved unknown substrate Details DB00520 Caspofungin approved unknown substrate Details DB00275 Olmesartan approved, investigational unknown substrate Details DB00177 Valsartan approved, investigational unknown substrate Details DB01583 Liotrix approved unknown substrate Details DB06176 Romidepsin approved, investigational unknown inhibitor Details DB08855 Leukotriene C4 experimental, investigational unknown Details DB00783 Estradiol approved, investigational, vet_approved unknown Details DB02691 Glycocholic acid experimental, investigational unknown Details DB05804 Prasterone sulfate investigational unknown Details DB00451 Levothyroxine approved unknown inhibitor Details DB08861 DPDPE experimental unknown Details DB08862 Cholecystokinin approved, investigational unknown substrate Details DB00950 Fexofenadine approved, investigational unknown substrate Details DB01095 Fluvastatin approved unknown substrate Details DB08860 Pitavastatin approved unknown substrate Details DB01098 Rosuvastatin approved unknown Details DB06772 Cabazitaxel approved unknown inhibitor Details DB08864 Rilpivirine approved unknown inhibitor Details DB08884 Gadoxetic acid approved unknown substrate Details DB08912 Dabrafenib approved, investigational no substrateinhibitor Details DB01076 Atorvastatin approved no substrate Details DB00688 Mycophenolate mofetil approved, investigational unknown substrate Details DB00175 Pravastatin approved no substrate Details DB01229 Paclitaxel approved, vet_approved unknown substrate Details DB01248 Docetaxel approved, investigational unknown substrate Details DB01211 Clarithromycin approved unknown Details DB09054 Idelalisib approved no inhibitor Details DB09292 Sacubitril approved unknown inhibitor Details DB09102 Daclatasvir approved, investigational unknown inhibitor Details DB05239 Cobimetinib approved, investigational no inhibitor Details DB11362 Selexipag approved no substrate Details DB06403 Ambrisentan approved, investigational unknown substrate Details DB11575 Grazoprevir approved no substrate Details DB09137 Technetium Tc-99m mebrofenin approved no substrate Details DB13154 Parachlorophenol approved unknown substrate Details DB13139 Levosalbutamol approved, investigational no substrate Details DB13153 Levomenol approved, experimental unknown substrate Details DB11613 Velpatasvir approved, investigational no inhibitortransporter Details DB06290 Simeprevir approved unknown substrateinhibitor Details DB06749 Ginsenoside Rb1 nutraceutical unknown inhibitor Details DB06750 Ginsenoside Rg1 nutraceutical unknown Details DB05016 Ataluren approved, investigational no inhibitor Details DB12026 Voxilaprevir approved, investigational no substrateinhibitor Details DB13874 Enasidenib approved, investigational unknown inhibitor Details DB13878 Pibrentasvir approved, investigational unknown inhibitor Details DB13879 Glecaprevir approved, investigational unknown substrateinhibitor Details DB12070 Letermovir approved, investigational no substrate Details DB12332 Rucaparib approved, investigational no inhibitor Details DB11817 Baricitinib approved, investigational unknown inhibitor Details DB13952 Estradiol acetate approved, investigational, vet_approved unknown Details DB13953 Estradiol benzoate approved, investigational, vet_approved unknown Details DB13954 Estradiol cypionate approved, investigational, vet_approved unknown Details DB13955 Estradiol dienanthate approved, investigational, vet_approved unknown Details DB13956 Estradiol valerate approved, investigational, vet_approved unknown Details DB09297 Paritaprevir approved, investigational unknown substrateinhibitor Details DB00975 Dipyridamole approved unknown inhibitor Details DB01072 Atazanavir approved, investigational unknown inhibitor Details DB00541 Vincristine approved, investigational unknown inhibitor Details DB09142 Sincalide approved unknown substrate Details DB00602 Ivermectin approved, investigational, vet_approved unknown inhibitor Details DB01149 Nefazodone approved, withdrawn unknown inhibitor Details DB00220 Nelfinavir approved no inhibitor Details DB01051 Novobiocin approved, investigational, vet_approved, withdrawn unknown inhibitor Details DB00646 Nystatin approved, vet_approved unknown inhibitor Details DB11869 Valspodar investigational unknown inhibitor Details DB09298 Silibinin experimental, investigational unknown inhibitor Details DB00795 Sulfasalazine approved no inhibitor Details DB00932 Tipranavir approved, investigational unknown inhibitor Details DB09065 Cobicistat approved unknown inhibitor Details DB00199 Erythromycin approved, investigational, vet_approved unknown substrateinhibitor Details DB01601 Lopinavir approved unknown inhibitor Details DB00976 Telithromycin approved unknown inhibitor Details DB01590 Everolimus approved unknown inhibitor Details DB11586 Asunaprevir approved, investigational, withdrawn unknown inhibitor Details DB05928 Dovitinib investigational unknown inhibitor Details DB11753 Rifamycin approved, investigational no inhibitor Details DB11855 Revefenacin approved, investigational no substrate Details DB00091 Cyclosporine approved, investigational, vet_approved no inhibitor Details DB00834 Mifepristone approved, investigational no inhibitor Details DB00257 Clotrimazole approved, vet_approved unknown inducer Details DB00396 Progesterone approved, vet_approved unknown inducer Details DB13946 Testosterone undecanoate approved, investigational unknown substrate Details DB09299 Tenofovir alafenamide approved no substrate Details DB00481 Raloxifene approved, investigational unknown substrate Details DB11942 Selinexor approved, investigational unknown inhibitor Details DB00394 Beclomethasone dipropionate approved, investigational unknown inhibitor Details DB00641 Simvastatin approved unknown Details DB00227 Lovastatin approved, investigational unknown Details DB12978 Pexidartinib approved, investigational unknown inhibitor Details DB12500 Fedratinib approved, investigational unknown inhibitor Details DB11757 Istradefylline approved, investigational unknown inhibitor Details DB01241 Gemfibrozil approved unknown inhibitor Details DB04855 Dronedarone approved no inhibitor Details DB00624 Testosterone approved, investigational unknown substrate Details DB15444 Elexacaftor approved, investigational unknown inhibitor Details DB14962 Trastuzumab deruxtecan approved, investigational unknown substrate Details DB15328 Ubrogepant approved, investigational unknown substrateinhibitor Details DB01211 Clarithromycin approved unknown inhibitor Details DB12941 Darolutamide approved, investigational unknown inhibitor Details DB12457 Rimegepant approved, investigational unknown inhibitor Details DB11936 Bempedoic acid approved, investigational unknown substrateinhibitor Details DB00503 Ritonavir approved, investigational unknown inhibitor Details DB01708 Prasterone approved, investigational, nutraceutical unknown substrate Details DB14761 Remdesivir approved, investigational unknown inhibitor Details DB09038 Empagliflozin approved unknown substrate Details DB00188 Bortezomib approved, investigational no inhibitor Details DB12674 Lurbinectedin approved, investigational unknown inhibitor Details DB11796 Fostemsavir approved, investigational unknown inhibitor Details DB15719 Belantamab mafodotin approved unknown substrate Details DB15822 Pralsetinib approved, investigational no inhibitor Details DB06448 Lonafarnib approved, investigational no inhibitor Details DB06137 Tirbanibulin approved, investigational no inhibitor Details DB11632 Opicapone approved, investigational no substrate Details DB09078 Lenvatinib approved, investigational unknown inhibitor Details DB08995 Diosmin approved, investigational unknown Details DB11886 Infigratinib approved, investigational no inhibitor Details DB12471 Ibrexafungerp approved, investigational unknown inhibitor Details DB12151 Brincidofovir approved, investigational no substrate Details DB15463 Belzutifan approved, investigational no substrate Details DB12265 Fexinidazole approved, investigational unknown inhibitor Details DB16098 Atogepant approved, investigational no substrateinhibitor Details DB12597 Asciminib approved, investigational no inhibitor Details DB15413 Pafolacianine approved, investigational no substrate Details DB12713 Sotagliflozin approved, investigational no inhibitor Details DB15575 Padeliporfin approved, experimental unknown inhibitor Details DB06813 Pralatrexate approved, investigational no substrate Details DB00619 Imatinib approved no substrate Details DB16650 Deucravacitinib approved, investigational unknown inhibitor Details DB17083 Linzagolix approved unknown substrateinhibitor Details DB16267 Olutasidenib approved, investigational no inhibitor Details DB00244 Mesalazine approved no substrate Details DB11682 Daprodustat approved, investigational no inhibitor Details DB12548 Sparsentan approved, investigational unknown inhibitor Details DB15688 Zavegepant investigational unknown substrate Details DB06045 Trofinetide investigational unknown inhibitor Details